Effects of Decentralized Sequencing on National Listeria monocytogenes Genomic Surveillance, Australia, 2016–2023

IF 7.2 2区 医学 Q1 IMMUNOLOGY
Patiyan Andersson, Sally Dougall, Karolina Mercoulia, Kristy A. Horan, Torsten Seemann, Jake A. Lacey, Tuyet Hoang, Lex E.X. Leong, David Speers, Louise Cooley, Karina Kennedy, Rob Baird, Rikki Graham, Qinning Wang, Avram Levy, Dimitrios Menouhos, Norelle L. Sherry, Susan A. Ballard, Vitali Sintchenko, Amy V. Jennison, Benjamin P. Howden
{"title":"Effects of Decentralized Sequencing on National Listeria monocytogenes Genomic Surveillance, Australia, 2016–2023","authors":"Patiyan Andersson, Sally Dougall, Karolina Mercoulia, Kristy A. Horan, Torsten Seemann, Jake A. Lacey, Tuyet Hoang, Lex E.X. Leong, David Speers, Louise Cooley, Karina Kennedy, Rob Baird, Rikki Graham, Qinning Wang, Avram Levy, Dimitrios Menouhos, Norelle L. Sherry, Susan A. Ballard, Vitali Sintchenko, Amy V. Jennison, Benjamin P. Howden","doi":"10.3201/eid3113.241357","DOIUrl":null,"url":null,"abstract":"<p>We assessed turnaround times in the national <em>Listeria monocytogenes</em> genomic surveillance system in Australia before and after decentralized sequencing. Using 1,204 samples collected during 2016–2023, we observed statistically significant reductions in median time from sample collection to issuance of national genomic surveillance report to 26 days, despite sample numbers doubling in 2022 and 2023. During 2016–2018, all jurisdictions referred samples to the National Listeria Reference Laboratory for sequencing and analysis, but as jurisdictional sequencing capacity increased, 4 jurisdictions transitioned to sequencing their own samples and referring sequence data to the national laboratory. One jurisdiction had well-established genomics capacity, transitioned without noticeable disruption, and continued to improve. Another 3 jurisdictions initially had increased turnaround times, highlighting the need for defined sequence referral mechanisms. Overall, timeliness and throughput improved, and sequencing decentralization strengthened Australia’s genomic surveillance system while maintaining timeliness. The practices described could be beneficial and achievable in other countries.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"103 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3113.241357","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We assessed turnaround times in the national Listeria monocytogenes genomic surveillance system in Australia before and after decentralized sequencing. Using 1,204 samples collected during 2016–2023, we observed statistically significant reductions in median time from sample collection to issuance of national genomic surveillance report to 26 days, despite sample numbers doubling in 2022 and 2023. During 2016–2018, all jurisdictions referred samples to the National Listeria Reference Laboratory for sequencing and analysis, but as jurisdictional sequencing capacity increased, 4 jurisdictions transitioned to sequencing their own samples and referring sequence data to the national laboratory. One jurisdiction had well-established genomics capacity, transitioned without noticeable disruption, and continued to improve. Another 3 jurisdictions initially had increased turnaround times, highlighting the need for defined sequence referral mechanisms. Overall, timeliness and throughput improved, and sequencing decentralization strengthened Australia’s genomic surveillance system while maintaining timeliness. The practices described could be beneficial and achievable in other countries.

分散测序对澳大利亚单核增生李斯特菌基因组监测的影响,2016-2023
我们评估了澳大利亚国家单核增生李斯特菌基因组监测系统在分散测序前后的周转时间。使用2016-2023年期间收集的1204个样本,我们观察到从样本收集到发布国家基因组监测报告的中位数时间在统计上显着减少到26天,尽管样本数量在2022年和2023年翻了一番。在2016-2018年期间,所有司法管辖区都将样本提交给国家李斯特菌参考实验室进行测序和分析,但随着司法管辖区测序能力的增加,4个司法管辖区转向对自己的样本进行测序,并将序列数据提交给国家实验室。一个司法管辖区拥有完善的基因组学能力,在过渡过程中没有明显的中断,并继续改善。另外3个司法管辖区最初增加了周转时间,强调需要确定顺序转诊机制。总体而言,时效性和吞吐量得到了提高,测序权力下放在保持时效性的同时加强了澳大利亚的基因组监测系统。所描述的做法在其他国家可能是有益的和可实现的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Emerging Infectious Diseases
Emerging Infectious Diseases 医学-传染病学
CiteScore
17.30
自引率
1.70%
发文量
505
审稿时长
1 months
期刊介绍: Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信